CLINICAL SIGNIFICANCE OF ANTIBODY TO THE HEPATITIS DELTA VIRUS IN SYMPTOMLESS HBsAg CARRIERS

Rizzetto, 1985, Delta hepatitis-Present status, J Hepatol, 1, 187, 10.1016/S0168-8278(85)80766-2

Mushawar, 1984, Interpretation of hepatitis B virus and hepatitis delta virus serologic profiles, Pathologist, 38, 648—50

Rizzetto, 1979, Incidence and significance of antibodies to delta antigen in hepatitis B virus infection, Lancet, ii, 986, 10.1016/S0140-6736(79)92561-3

Smedile, 1983, Epidemiological patterns of infection with the hepatitis B virus associated delta (δ) agent in Italy, Am J Epidemiol, 117, 223, 10.1093/oxfordjournals.aje.a113533

Rizzetto, 1980, The hepatitis B virus associated delta antigen (δ): isolation from liver, development of solid phase radioimmunoassays for delta and anti-delta and partial characterization of delta, J Immunol, 125, 318, 10.4049/jimmunol.125.1.318

Smedile, 1982, Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (δ) antigen. Clinical significance in infection, J Med Virol, 9, 131, 10.1002/jmv.1890090208

Bianchi, 1977, Acute and chronic hepatitis revisited, Lancet, ii, 914

Rizzetto, 1983, Chronic HBsAg hepatitis with intrahepatic expression of delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment, Ann Intern Med, 98, 437, 10.7326/0003-4819-98-4-437

Remecke, 1972, A study of Australia-antigen-positive blood donors and their recipients, with special reference to liver histology, N Engl J Med, 286, 867, 10.1056/NEJM197204202861604

Ricci, 1973, Carriers of Hepatitis B Antigen: An epidemiologic and histologic study, J Infect Dis, 128, 125, 10.1093/infdis/128.1.125

Woolf, 1974, Asymptomatic liver disease in hepatitis B antigen carriers, J Clin Path, 27, 348, 10.1136/jcp.27.5.348

Lesnicar, 1975, The significance of HB antigenemia in apparently healthy persons in the clinic for liver diseases, Acta Hepato-Gastroenterol, 22, 297

Feinman, 1975, Clinical and epidemiological significance of the HBsAg (Australia antigen): carrier state, Gastroenterology, 68, 113, 10.1016/S0016-5085(75)80055-2

Piccinino, 1977, Liver histology in 34 HBsAg long-term healthy carriers, Acta Hepato-Gastroenterol, 23, 148

Shrago, 1977, Hepatic pathologic condition in asymptomatic Australia antigen carriers, Arch Pathol Lab Med, 101, 648

Velasco, 1978, Clinical and pathological study of asymptomatic HBsAg carriers in Chile, Gut, 19, 569, 10.1136/gut.19.6.569

Koretz, 1978, Hepatitis B surface antigen carriers-to biopsy or not to biopsy, Gastroenterology, 75, 860, 10.1016/0016-5085(78)90470-5

De Franchis, 1980, Chronic asymptomatic HBsAg carriers: histologic abnormalities and diagnostic and prognostic value ofserologic markers of the HBV, Gastroenterology, 79, 521, 10.1016/0016-5085(80)90378-9

N. Nath, Ct Fang, H. Berberian, Ik Mushahwar, Ry Dodd, Antibodies to delta antigen in asymptomatic HBsAg reactive blood donors in the United States and its association with other markers of hepatitis B virus, Am J Epidemiol ((in press)).

Hadziyannis, 1983, Delta antigen positive chronic liver disease in Greece: clinical aspects and natural course, 209

Govindarajan, 1983, Prevalence of delta antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis, Gastroenterology, 85, 160, 10.1016/S0016-5085(83)80243-1

Farci, 1984, IgM anti-delta: a marker of active delta hepatitis, Hepatology, 4, 1096

Purcell, 1983, Experimental transmission of the delta agent to chimpanzees, 79

Rosina, 1985, Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study, N Engl J Med, 312, 1488, 10.1056/NEJM198506063122305